Della F. Makower

Della F. Makower, M.D. is an Oncology specialist at Montefiore Medical Center with a robust research portfolio focusing on breast cancer treatment, chemotherapy effects, and health disparities. With 49 publications and an h-index of 21, she has made significant contributions to understanding cancer treatment outcomes, particularly regarding social determinants of health and racial disparities in cancer care.

Her research interests span multiple critical areas in oncology including:

• Breast Cancer (100% research focus)
• Chemotherapy (76% research focus)
• Recurrent Disease (61% research focus)
• Malignant Neoplasm (44% research focus)
• Endocrine Therapy (30% research focus)
• Hormone Receptor research (25% research focus)

Dr. Makower's recent publications demonstrate a strong emphasis on health equity, with multiple studies examining racial disparities in cardiotoxicity, the impact of social determinants on cancer treatment outcomes, and specialized research on breast cancer in diverse patient populations. Her work frequently appears in high-impact journals including the Journal of the American Heart Association, Breast Cancer Research and Treatment, Cancer, and the Journal of Clinical Oncology.

Notable research initiatives include:

• ECOG-ACRIN EA1131 trial comparing adjuvant platinum versus capecitabine for triple-negative breast cancer
• ECOG-ACRIN EAZ171 trial investigating germline predictors of taxane-induced neuropathy in Black women with breast cancer
• Studies examining the relationship between social determinants of health and anthracycline cardiotoxicity
• Research on the impact of the COVID-19 pandemic on breast cancer screening and diagnosis

Her collaborative approach is evident in the multi-institutional nature of her research, with frequent collaborations across major cancer research networks. Dr. Makower's work has garnered significant attention, with multiple studies picked up by news outlets and discussed on social media platforms including X (Twitter) and Facebook.